Allied Market Research
Loading...
0
New
New
2021
Hospital-acquired Infection Control Market

Hospital-Acquired Infection Control Market by Product & Service (Sterilization, Cleaning & Disinfection Products, Protective Barriers, and Endoscope Reprocessing Products), Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2022–2030

A10994
Pages: 277
Jul 2021 | 814 Views
   
Author(s) : Sushant Terdale , Onkar Sumant
Tables: 123
Charts: 48
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hospital-acquired Infection Control Market

Request Now !

The global hospital-acquired infection control market was valued at $19,958 million in 2020, and is projected to reach $25,006 million by 2030, registering a CAGR of 4.6% from 2022 to 2030. Infections are majorly caused by microorganisms such as virus, bacteria, and fungi, or parasites. Infections can be of different types such as stomach and intestinal infections, lung & respiratory infections, eye infections, ear infections, hospital-acquired infections, skin infections, and sexually transmitted infections. Hospital-acquired infections can be caused by the cross-infection from surface and skin of patient, equipment, and healthcare staff. Different types of products and services available to control hospital-acquired infections include sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products.

Hospital-Acquired-Infection-Control-Market-2022-2030

Get more information on this report : Request Sample Pages

Increase in incidence of hospital-acquired infections, rise in number of surgical procedures that require high-intensity infection prevention & control, surge in number of government awareness program to ensure high degree infection prevention, rise in geriatric population, and surge in cases of chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders are the major factors that are expected to drive the growth of the market. In addition, rise in need for sterilization and disinfection in hospitals & clinics, technological advancements in sterilization & disinfection equipment, surge in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, increase in production of medical nonwovens & single-use products due to surge in cases of COVID-19 are expected to drive the growth of the hospital acquired infection control market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the hospital acquired infection control market. Conversely, rise in adoption of single-use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The hospital-acquired infection control product manufacturers are expanding their production capacity to manufacture medical nonwoven and gloves products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases and surge in need for healthcare workers are expected to drive the demand for protective barrier products and disposable hospital supplies. Thus, COVID-19 infection opened new avenues for manufacturers of hospital-acquired infection control products. 

Hospital-acquired Infection Control Market Segmentation  

The hospital-acquired infection control market is segmented into product & service, infection type, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, sterilization consumables and accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. As per cleaning & disinfection products, the market is segregated into disinfectants, disinfectors equipment, and others. According to infection type, the market is categorized into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others. By end user, the market is categorized into hospitals & clinics, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review 

On the basis of product & service, the protective barrier segment is the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to increase in public awareness toward personal hygiene; rise in number of surgeries; increase in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases; and increase in production of medical nonwoven products and gloves. 

Hospital-Acquired Infection Control Market
By Product and Service

Your browser does not support the canvas element.

Protective barriers segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By end user, the hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market, owing to rise in volume of surgical procedures performed in hospitals, surge in prevalence of hospital-acquired infections, increase in number of hospitals & clinics, and surge in geriatric population coupled with rise in cases of chronic diseases.

Hospital-Acquired Infection Control Market
By End User

Your browser does not support the canvas element.

Hospitals & Clinics segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific hospital-acquired infection control market  

Asia-Pacific presents lucrative opportunities for key players operating in the hospital-acquired infection control market, owing to increase in incidence of hospital-acquired infections in emerging economies, rise in adoption of sterilization & disinfection equipment, development of the R&D sector, rise in healthcare reforms, and technological advancements in medical device manufacturing, Moreover, rise in demand for medical nonwoven products, surge in funding from government & nongovernment sectors to create awareness about infection prevention & control, and presence of high population base contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the hospital-acquired infection control market in the region.

Hospital-Acquired Infection Control Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 5.4% during 2022-2030.

Get more information on this report : Request Sample Pages

The key players profiled in this report include 3M Company, Belimed AG, Ecolab Inc, Fortive (Advanced Sterilization Products), Getinge AB, Matachana Group, Miele Group, MMM Group, Sotera Health LLC, and Steris Plc. (Cantel Medical Corporation).

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the hospital acquired infection control market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers hospital acquired infection control market analysis from 2022 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global hospital acquired infection control market growth.

Key Market Segments

By Product & Service

  • Sterilization
    • Sterilization Product
      • Heat Sterilization Equipment
      • Low Temperature Sterilization Equipment
      • Radiation Sterilization Equipment
      • Other Sterilization Equipment
    • Contract Sterilization Services
    • Sterilization Consumables & Accessories
  • Cleaning & Disinfection Products
    • Disinfectants
    • Disinfectors Equipment
    • Others
  • Protective Barriers
  • Endoscope Reprocessing Products

By Infection Type

  • Hospital-acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidence of hospital-acquired infections
3.5.1.2.Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.1.3.Increase in geriatric population and rise in incidence of chronic diseases

3.5.2.Restraint

3.5.2.1.Adverse effects of chemical disinfectants

3.5.3.Opportunities

3.5.3.1.High market growth potential in emerging markets

3.5.4.Impact analysis

3.6.Covid-19 impact analysis on hospital-acquired infection control market

CHAPTER 4:HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE

4.1.Overview

4.1.1.Market size and forecast

4.2.Sterilization

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type

4.2.4.1.Sterilization product

4.2.4.1.1.Market size and forecast, by type

4.2.4.1.1.1.Heat sterilization equipment

4.2.4.1.1.1.1.Market size and forecast

4.2.4.1.1.2.Low temperature sterilization equipment

4.2.4.1.1.2.1.Market size and forecast

4.2.4.1.1.3.Radiation sterilization equipment

4.2.4.1.1.3.1.Market size and forecast

4.2.4.1.1.4.Other sterilization equipment

4.2.4.1.1.4.1.Market size and forecast

4.2.4.2.Contract sterilization services
4.2.4.3.Sterilization consumables & accessories

4.3.Cleaning & disinfection products

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type

4.3.4.1.Disinfectants

4.3.4.1.1.Market size and forecast

4.3.4.2.Disinfector equipment

4.3.4.2.1.Market size and forecast

4.3.4.3.Others

4.3.4.3.1.Market size and forecast

4.4.Protective barriers

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Endoscope reprocessing products

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

CHAPTER 5:HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospital-acquired pneumonia

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Bloodstream infections

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Surgical site infections

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Gastrointestinal infections

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Urinary tract infections

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

CHAPTER 6:HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & clinics

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Ambulatory surgical centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. hospital-acquired infection control market, by product & service
7.2.2.1.2.U.S. hospital-acquired infection control market, by infection type
7.2.2.1.3.U.S. hospital-acquired infection control market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada hospital-acquired infection control market, by product & service
7.2.2.2.2.Canada hospital-acquired infection control market, by infection type
7.2.2.2.3.Canada hospital-acquired infection control market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico hospital-acquired infection control market, by product & service
7.2.2.3.2.Mexico hospital-acquired infection control market, by infection type
7.2.2.3.3.Mexico hospital-acquired infection control market, by end user

7.2.3.North America market size and forecast, by product & service
7.2.4.North America market size and forecast, by infection type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany hospital-acquired infection control market, by product & service
7.3.2.1.2.Germany hospital-acquired infection control market, by infection type
7.3.2.1.3.Germany hospital-acquired infection control market, by end user

7.3.2.2.France

7.3.2.2.1.France hospital-acquired infection control market, by product & service
7.3.2.2.2.France hospital-acquired infection control market, by infection type
7.3.2.2.3.France hospital-acquired infection control market, by end user

7.3.2.3.UK

7.3.2.3.1.UK hospital-acquired infection control market, by product & service
7.3.2.3.2.UK hospital-acquired infection control market, by infection type
7.3.2.3.3.UK hospital-acquired infection control market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy hospital-acquired infection control market, by product & service
7.3.2.4.2.Italy hospital-acquired infection control market, by infection type
7.3.2.4.3.Italy hospital-acquired infection control market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain hospital-acquired infection control market, by product & service
7.3.2.5.2.Spain hospital-acquired infection control market, by infection type
7.3.2.5.3.Spain hospital-acquired infection control market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe hospital-acquired infection control market, by product & service
7.3.2.6.2.Rest of Europe hospital-acquired infection control market, by infection type
7.3.2.6.3.Rest of Europe hospital-acquired infection control market, by end user

7.3.3.Europe market size and forecast, by product & service
7.3.4.Europe market size and forecast, by infection type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan hospital-acquired infection control market, by product & service
7.4.2.1.2.Japan hospital-acquired infection control market, by infection type
7.4.2.1.3.Japan hospital-acquired infection control market, by end user

7.4.2.2.China

7.4.2.2.1.China hospital-acquired infection control market, by product & service
7.4.2.2.2.China hospital-acquired infection control market, by infection type
7.4.2.2.3.China hospital-acquired infection control market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia hospital-acquired infection control market, by product & service
7.4.2.3.2.Australia hospital-acquired infection control market, by infection type
7.4.2.3.3.Australia hospital-acquired infection control market, by end user

7.4.2.4.India

7.4.2.4.1.India hospital-acquired infection control market, by product & service
7.4.2.4.2.India hospital-acquired infection control market, by infection type
7.4.2.4.3.India hospital-acquired infection control market, by end user

7.4.2.5.South Korea

7.4.2.5.1.South Korea hospital-acquired infection control market, by product & service
7.4.2.5.2.South Korea hospital-acquired infection control market, by infection type
7.4.2.5.3.South Korea hospital-acquired infection control market, by end user

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific hospital-acquired infection control market, by product & service
7.4.2.6.2.Rest of Asia-Pacific hospital-acquired infection control market, by infection type
7.4.2.6.3.Rest of Asia-Pacific hospital-acquired infection control market, by end user

7.4.3.Asia-Pacific market size and forecast, by product & service
7.4.4.Asia-Pacific market size and forecast, by infection type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil hospital-acquired infection control market, by product & service
7.5.2.1.2.Brazil hospital-acquired infection control market, by infection type
7.5.2.1.3.Brazil hospital-acquired infection control market, by end user

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia hospital-acquired infection control market, by product & service
7.5.2.2.2.Saudi Arabia hospital-acquired infection control market, by infection type
7.5.2.2.3.Saudi Arabia hospital-acquired infection control market, by end user

7.5.2.3.South Africa

7.5.2.3.1.South Africa hospital-acquired infection control market, by product & service
7.5.2.3.2.South Africa hospital-acquired infection control market, by infection type
7.5.2.3.3.South Africa hospital-acquired infection control market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA hospital-acquired infection control market, by product & service
7.5.2.4.2.Rest of LAMEA hospital-acquired infection control market, by infection type
7.5.2.4.3.Rest of LAMEA hospital-acquired infection control market, by end user

7.5.3.LAMEA market size and forecast, by product & service
7.5.4.LAMEA market size and forecast, by infection type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.3M Company

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Belimed AG.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.Ecolab Inc.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.Fortive Corporation (Advanced Sterilization Products).

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.Getinge AB

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.Matachana Group

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments

8.7.Miele Group. (Steelco)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio

8.8.MMM Group

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio

8.9.Sotera Health Inc.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.Steris Plc (Cantel Medical Corporation)

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 02.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY REGION, 2020-2030 ($MILLION)
TABLE 03.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION PRODUCT, BY TYPE, 2020–2030 ($MILLION)
TABLE 05.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY REGION, 2020-2030 ($MILLION)
TABLE 06.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2020–2030 ($MILLION)
TABLE 07.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY REGION, 2020-2030 ($MILLION)
TABLE 09.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 10.HOSPITAL-ACQUIRED PNEUMONIA CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11.HOSPITAL-ACQUIRED BLOODSTREAM INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 12.HOSPITAL-ACQUIRED SURGICAL SITE INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13.HOSPITAL-ACQUIRED GASTROINTESTINAL INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14.HOSPITAL-ACQUIRED URINARY TRACT INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.HOSPITAL-ACQUIRED OTHER INFECTION CONTROL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 18.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 19.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 20.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 21.NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 22.U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 23.U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 24.U.S. HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 25.CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 26.CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 27.CANADA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 28.MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 29.MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 30.MEXICO HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 31.NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 32.NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 33.NORTH AMERICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 34.EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 35.GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 36.GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 37.GERMANY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 38.FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 39.FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 40.FRANCE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 41.UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 42.UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 43.UK HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 44.ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 45.ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 46.ITALY HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 47.SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 48.SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 49.SPAIN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 51.REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 52.REST OF EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 53.EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 54.EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 55.EUROPE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 56.ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 57.JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 58.JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 59.JAPAN HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 60.CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 61.CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 62.CHINA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 63.AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 64.AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 65.AUSTRALIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 66.INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 67.INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 68.INDIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 69.SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 70.SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 71.SOUTH KOREA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 75.ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 76.ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 77.ASIA-PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78.LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 79.BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 80.BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 81.BRAZIL HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 82.SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 83.SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 84.SAUDI ARABIA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 85.SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 86.SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 87.SOUTH AFRICA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 88.REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 89.REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 90.REST OF LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 91.LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2030 ($MILLION)
TABLE 92.LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY INFECTION TYPE, 2020–2030 ($MILLION)
TABLE 93.LAMEA HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 94.3M: COMPANY SNAPSHOT
TABLE 95.3M: OPERATING SEGMENTS
TABLE 96.3M: PRODUCT PORTFOLIO
TABLE 97.BELIMED: COMPANY SNAPSHOT
TABLE 98.BELIMED: OPERATING SEGMENTS
TABLE 99.BELIMED: PRODUCT PORTFOLIO
TABLE 100.ECOLAB: COMPANY SNAPSHOT
TABLE 101.ECOLAB: OPERATING SEGMENTS
TABLE 102.ECOLAB: PRODUCT PORTFOLIO
TABLE 103.FORTIVE: COMPANY SNAPSHOT
TABLE 104.FORTIVE: OPERATING SEGMENTS
TABLE 105.FORTIVE: PRODUCT PORTFOLIO
TABLE 106.GETINGE: COMPANY SNAPSHOT
TABLE 107.GETINGE: OPERATING SEGMENTS
TABLE 108.GETINGE: PRODUCT PORTFOLIO
TABLE 109.MATACHNA: COMPANY SNAPSHOT
TABLE 110.MATACHANA: OPERATING SEGMENTS
TABLE 111.MATACHANA: PRODUCT PORTFOLIO
TABLE 112.MIELE: COMPANY SNAPSHOT
TABLE 113.MIELE: OPERATING SEGMENTS
TABLE 114.MIELE: PRODUCT PORTFOLIO
TABLE 115.MMM COMPANY SNAPSHOT
TABLE 116.MMM: OPERATING SEGMENTS
TABLE 117.MMM: PRODUCT PORTFOLIO
TABLE 118.SOTERA HEALTH: COMPANY SNAPSHOT
TABLE 119.SOTERA HEALTH: OPERATING SEGMENTS
TABLE 120.SOTERA HEALTH: PRODUCT PORTFOLIO
TABLE 121.STERIS: COMPANY SNAPSHOT
TABLE 122.STERIS: OPERATING SEGMENTS
TABLE 123.STERIS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.HIGH THREAT OF SUBSTITUTES
FIGURE 04.HIGH THREAT OF NEW ENTRANTS
FIGURE 05.MODERATE INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 09.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, 2020–2030 ($MILLION)
FIGURE 10.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR LOW TEMPERATURE STERILIZATION EQUIPMENT, 2020–2030 ($MILLION)
FIGURE 11.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR RADIATION STERILIZATION EQUIPMENT, 2020–2030 ($MILLION)
FIGURE 12.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER STERILIZATION EQUIPMENT, 2020–2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS, 2020–2030 ($MILLION)
FIGURE 15.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTOR EQUIPMENT, 2020–2030 ($MILLION)
FIGURE 16.HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS CLEANING & DISINFECTION PRODUCTS, 2020–2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED PNEUMONIA CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED BLOODSTREAM INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS HOSPITAL-ACQUIRED GASTROINTESTINAL INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS HOSPITAL-ACQUIRED URINARY TRACT INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED OTHER INFECTION CONTROL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 28.3M:NET SALES,2018-2020 ($MILLION)
FIGURE 29.3M: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.3M: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31.BELIMED:NET SALES, 2018-2020 ($MILLION)
FIGURE 32.BELIMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.BELIMED: REVENUE SHARE BY REGION 2020 (%)
FIGURE 34.ECOLAB: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.ECOLAB: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.ECOLAB: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.FORTIVE: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.FORTIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.FORTIVE: REVENUE SHARE BY REGION 2020 (%)
FIGURE 40.GETINGE: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.GETINGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.SOTERA HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.SOTERA HEALTH: REVENUE SHARE BY SEGMENTS, 2020(%)
FIGURE 45.SOTERA HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.STERIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.STERIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48.STERIS: REVENUE SHARE BY REGION, 2020 (%)

 
 

Hospital-acquired infection control consists of numerous products & services which are designed to prevent & control the spread of HAI infections originating from hospitals. These HAI products are designed to be used across different forms of healthcare facilities.

The factors such as rise in stringency in terms of regulations & compliances being imposed by medical authorities in terms of infection prevention & control from different healthcare facilities is anticipated to act as a growth driver for hospital-acquired infection control market. In addition, increase in medical tourism in emerging countries such as China and India, rise in awareness programs of hospital-acquired infection control methods promoted by private organizations, and high demand for advanced hospital-acquired infection control products boost the growth of the market. However, concerns regarding the safety of reprocessed instruments are expected to hinder the growth of the hospital-acquired infection control market.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Hospital-Acquired Infection Control market is $19,958.3 million in 2020.

A. The forcast period for Hospital-Acquired Infection Control market is 2021 to 2030

A. The market value of Hospital-Acquired Infection Control market in 2021 is $19,203.2 million.

A. The base year is 2020 in Hospital-Acquired Infection Control market

A. Top companies such as Steris Plc (Cantel Medical Corporation), Getinge AB, 3M Company, Fortive (Advanced Sterilization Products), Sotera Health Llc, Belimed AG, and Ecolab Inc held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Protective barriers segment is the most influencing segment owing to increase in focus towards preventing hospital acquired infections (HAIs), rapid developments in nonwovens production technology, rise in number of surgeries, rise in patient awareness toward incontinence products, and surge in adoption of nanofiber and high-performance material technologies in nonwoven product manufacturing

A. Increase in number of surgical procedures, rise in incidence of hospital acquired infection, technological advancements in sterilization and disinfection technologies, surge in geriatric population, increase in government and non-government initiatives relating to spreading awareness concerning need for disinfection and need of proper hygiene are the major factors that boost the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to increase in awareness related to personal hygiene, rise in number of surgical procedures, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system.

A. Hospital-acquired infection control is concerned with preventing and controlling health care associated infections.

A. Hospital-acquired infection control consists of numerous products & services which are designed to prevent & control the spread of HAI infections originating from hospitals and other healthcare settings.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Hospital-acquired Infection Control Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers